내시경 역행 췌담관 조영술(ERCP) 시장 보고서 : 동향, 예측, 경쟁 분석(-2030년)
Endoscopic Retrograde Cholangiopancreatography Market Report: Trends, Forecast and Competitive Analysis to 2030
상품코드:1417393
리서치사:Lucintel
발행일:2024년 01월
페이지 정보:영문 150 - page report
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
내시경 역행 췌담관 조영술 동향과 예측
세계의 내시경 역행 췌담관 조영술 시장 규모는 2024년부터 2030년까지 CAGR 5.5%로 성장하고, 2030년까지 약 19억 달러에 달할 것으로 예측됩니다. 이 시장의 주요 성장 촉진요인은 암 이환율 상승, 최소침습 시술·수술에 대한 지향 상승, 정부나 헬스케어 기관에서 재정적 커미트먼트 상승입니다. 세계의 내시경 역행 췌담관 조영술 시장의 미래는 병원이나 외래 수술 센터·클리닉 시장에서의 기회로 유망해 보입니다.
내시경 역행 췌담관 조영술 시장 인사이트
Lucintel은 소화기질환 이환율 증가에 의해 예측기간 중 내시경 치료 장비가 최대 부문으로 남을 것으로 예측하고 있습니다.
이 시장 중에서 병원은 이러한 시설에서 폭넓은 ERCP 디바이스를 이용할 수 있기 때문에 최대 부문으로 남을 것으로 생각됩니다.
북미는 암 환자 증가와 첨단 ERCP 툴 도입으로 예측기간 동안 최대 지역으로 남을 것으로 생각됩니다.
자주 묻는 질문
Q1. 시장 규모는?
A1. 세계의 내시경 역행 췌담관 조영술 시장은 2030년까지 약 19억 달러에 달할 것으로 예상됩니다.
Q2. 시장 성장 예측은?
A2. 세계의 내시경 역행 췌담관 조영술 시장은 2024년부터 2030년까지 CAGR 5.5%로 성장할 전망입니다.
Q3. 시장의 성장에 영향을 미치는 주요 성장 촉진요인은?
A3. 이 시장의 주요 성장 촉진요인은 암 이환율 상승, 최소침습 시술·수술에 대한 지향 상승, 정부나 헬스케어 기관에서 재정적 커미트먼트 증대입니다.
Q4. 시장의 주요 부문은?
A4. 내시경 역행 췌담관 조영술 시장의 미래는 병원 및 외래 수술 센터·클리닉 시장에서의 기회에 의해 유망시 됩니다.
Q5. 시장의 주요 기업은?
A5. 내시경 역행 췌담관 조영술의 주요 기업은 다음과 같습니다.
Hobbs Medical
STERIS
Merit Medical Systems
TeleMed Systems
Changzhou Health Microport Medical Device
Q6. 향후 최대가 되는 시장 부문은?
A6. Lucintel은 소화기질환 이환율 증가에 의해 예측기간 중 내시경 치료 장비가 최대 부문으로 남을 것으로 예측하고 있습니다.
Q7. 시장에서 향후 5년 동안 최대가 될 것으로 예상되는 지역은?
A7. 북미는 암 환자 증가와 첨단 ERCP 툴 도입으로 예측기간 중에도 최대 지역으로 남을 것입니다.
Q8. 보고서 커스터마이징이 가능?
A8. 네, Lucintel은 추가 비용 없이 10% 커스터마이징을 제공합니다.
목차
제1장 주요 요약
제2장 세계의 내시경 역행 췌담관 조영술 시장 : 시장 역학
서론, 배경, 분류
공급망
산업 성장 촉진요인과 과제
제3장 시장 동향과 예측 분석(2018-2030년)
거시경제 동향(2018-2023년)과 예측(2024-2030년)
세계의 내시경 역행 췌담관 조영술 시장 동향(2018-2023년)과 예측(2024-2030년)
세계의 내시경 역행 췌담관 조영술 시장 : 제품별
내시경
내시경 치료 장비
가시화 시스템
에너지 디바이스
기타
세계의 내시경 역행 췌담관 조영술 시장 : 시술별
담도 괄약근 절개술
담도 스텐트 삽입술
담도 투석
췌괄약근 절개술
췌관 스텐트 삽입술
췌관 확장술
세계의 내시경 역행 췌담관 조영술 시장 : 최종 용도별
병원
외래 수술 센터·클리닉
기타
제4장 시장 동향과 예측 분석 : 지역별(2018-2030년)
세계의 내시경 역행 췌담관 조영술 시장 : 지역별
북미
유럽
아시아태평양
기타 지역
제5장 경쟁 분석
제품 포트폴리오 분석
운영상 통합
Porter's Five Forces 분석
제6장 성장 기회와 전략적 분석
성장 기회 분석
제품별
시술별
최종 용도별
지역별
세계의 내시경 역행 췌담관 조영술 시장 최신 동향
전략적 분석
신제품 개발
세계의 내시경 역행 췌담관 조영술 시장 능력 확대
세계의 내시경 역행 췌담관 조영술 시장 합병, 인수, 합작투자
인증과 라이선싱
제7장 유력 기업의 기업 개요
Hobbs Medical
STERIS
Merit Medical Systems
TeleMed Systems
Changzhou Health Microport Medical Device
KSM
영문 목차
영문목차
Endoscopic Retrograde Cholangiopancreatography Trends and Forecast
The future of the global endoscopic retrograde cholangiopancreatography market looks promising with opportunities in the hospital and ambulatory surgery center & clinic markets. The global endoscopic retrograde cholangiopancreatography market is expected to reach an estimated $1.9 billion by 2030 with a CAGR of 5.5% from 2024 to 2030. The major drivers for this market are elevated cancer rates, increasing inclination towards minimally invasive procedures and surgeries, and growing financial commitments from governments and healthcare institutions.
A more than 150-page report is developed to help in your business decisions.
Endoscopic Retrograde Cholangiopancreatography by Segment
The study includes a forecast for the global endoscopic retrograde cholangiopancreatography by product, procedure, end use, and region.
Endoscopic Retrograde Cholangiopancreatography Market by Product [Shipment Analysis by Value from 2018 to 2030]:
Endoscopes
Endotherapy Devices
Visualization Systems
Energy Devices
Others
Endoscopic Retrograde Cholangiopancreatography Market by Procedure [Shipment Analysis by Value from 2018 to 2030]:
Biliary Sphincterotomy
Biliary Stenting
Biliary Dialtation
Pancreatic Sphincterotomy
Pancreatic Duct Stenting
Pancreatic Duct Dilatation
Endoscopic Retrograde Cholangiopancreatography Market by End Use [Shipment Analysis by Value from 2018 to 2030]:
Hospitals
Ambulatory Surgery Centers & Clinics
Other
Endoscopic Retrograde Cholangiopancreatography Market by Region [Shipment Analysis by Value from 2018 to 2030]:
North America
Europe
Asia Pacific
The Rest of the World
List of Endoscopic Retrograde Cholangiopancreatography Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies endoscopic retrograde cholangiopancreatography companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the endoscopic retrograde cholangiopancreatography companies profiled in this report include-
Lucintel forecasts that endotherapy device will remain the largest segment over the forecast period due to growing incidence of gastrointestinal disorders.
Within this market, hospital will remain the largest segment due to availability of wide range of ERCP devices in these facilities.
North America will remain the largest region over the forecast period due to rising frequency of cancer cases and introduction of advanced ERCP tools in the region.
Features of the Global Endoscopic Retrograde Cholangiopancreatography Market
Market Size Estimates: Endoscopic retrograde cholangiopancreatography market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Endoscopic retrograde cholangiopancreatography market size by product, procedure, end use, and region in terms of value ($B).
Regional Analysis: Endoscopic retrograde cholangiopancreatography market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different products, procedures, end uses, and regions for the endoscopic retrograde cholangiopancreatography market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the endoscopic retrograde cholangiopancreatography market.
Analysis of competitive intensity of the industry based on Porter's Five Forces model.
FAQ
Q1. What is the endoscopic retrograde cholangiopancreatography market size?
Answer: The global endoscopic retrograde cholangiopancreatography market is expected to reach an estimated $1.9 billion by 2030.
Q2. What is the growth forecast for endoscopic retrograde cholangiopancreatography market?
Answer: The global endoscopic retrograde cholangiopancreatography market is expected to grow with a CAGR of 5.5% from 2024 to 2030.
Q3. What are the major drivers influencing the growth of the endoscopic retrograde cholangiopancreatography market?
Answer: The major drivers for this market are elevated cancer rates, increasing inclination towards minimally invasive procedures and surgeries, and growing financial commitments from governments and healthcare institutions.
Q4. What are the major segments for endoscopic retrograde cholangiopancreatography market?
Answer: The future of the endoscopic retrograde cholangiopancreatography market looks promising with opportunities in the hospital and ambulatory surgery center & clinic markets.
Q5. Who are the key endoscopic retrograde cholangiopancreatography market companies?
Answer: Some of the key endoscopic retrograde cholangiopancreatography companies are as follows.
Hobbs Medical
STERIS
Merit Medical Systems
TeleMed Systems
Changzhou Health Microport Medical Device
Q6. Which endoscopic retrograde cholangiopancreatography market segment will be the largest in future?
Answer: Lucintel forecasts that endotherapy device will remain the largest segment over the forecast period due to growing incidence of gastrointestinal disorders.
Q7. In endoscopic retrograde cholangiopancreatography market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region over the forecast period due to rising frequency of cancer cases and introduction of advanced ERCP tools in the region.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the endoscopic retrograde cholangiopancreatography market by product (endoscopes, endotherapy devices, visualization systems, energy devices, and others), procedure (biliary sphincterotomy, biliary stenting, biliary dialtation, pancreatic sphincterotomy, pancreatic duct stenting, and pancreatic duct dilatation), end use (hospitals, ambulatory surgery centers & clinics, and other), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
Table of Contents
1. Executive Summary
2. Global Endoscopic Retrograde Cholangiopancreatography Market : Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. Market Trends and Forecast Analysis from 2018 to 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Endoscopic Retrograde Cholangiopancreatography Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Endoscopic Retrograde Cholangiopancreatography Market by Product
3.3.1: Endoscopes
3.3.2: Endotherapy Devices
3.3.3: Visualization Systems
3.3.4: Energy Devices
3.3.5: Others
3.4: Global Endoscopic Retrograde Cholangiopancreatography Market by Procedure
3.4.1: Biliary Sphincterotomy
3.4.2: Biliary Stenting
3.4.3: Biliary Dialtation
3.4.4: Pancreatic Sphincterotomy
3.4.5: Pancreatic Duct Stenting
3.4.6: Pancreatic Duct Dilatation
3.5: Global Endoscopic Retrograde Cholangiopancreatography Market by End Use
3.5.1: Hospitals
3.5.2: Ambulatory Surgery Centers & Clinics
3.5.3: Other
4. Market Trends and Forecast Analysis by Region from 2018 to 2030
4.1: Global Endoscopic Retrograde Cholangiopancreatography Market by Region
4.2: North American Endoscopic Retrograde Cholangiopancreatography Market
4.2.2: North American Endoscopic Retrograde Cholangiopancreatography Market by End Use: Hospitals, Ambulatory Surgery Centers & Clinics, and Other
4.3: European Endoscopic Retrograde Cholangiopancreatography Market
4.3.1: European Endoscopic Retrograde Cholangiopancreatography Market by Product: Endoscopes, Endotherapy Devices, Visualization Systems, Energy Devices, and Others
4.3.2: European Endoscopic Retrograde Cholangiopancreatography Market by End Use: Hospitals, Ambulatory Surgery Centers & Clinics, and Other
